Theses/Dissertations - Chemistry & Biochemistry
Permanent URI for this collectionhttps://hdl.handle.net/2104/4476
Browse
Browsing Theses/Dissertations - Chemistry & Biochemistry by Subject "Antibiotic resistance."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Characterization of the metallo-ß-lactamase from Pseudomonas aeruginosa, IMP-1.(2014-06-11) Solida, Nicole R.; Kim, Sung-Kun, 1968-; Chemistry and Biochemistry.; Baylor University. Dept. of Chemistry and Biochemistry.The rate at which pathogenic bacteria are gaining antibiotic resistance has become increasingly alarming. Major contributors of this antibiotic resistance in microbes are a class of enzymes known as β-lactamases. These enzymes are effective in breaking down the most commonly prescribed antibiotics at present. This work investigates two separate metallo-β-lactamase enzymes, first IMP-1, which provides antibiotic resistance to Pseudomonas aeruginosa, and second Bla2, which grants antibiotic resistance to Bacillus anthracis. The main focus of this work was to investigate and characterize IMP-1 according to its activity and stability in temperature and pH. This was done in an effort to increase the general knowledge for potential inhibitors to be designed. The secondary focus of this work was to examine the ability of novel hydroxamate compounds to inhibit the growth of bacterial cells expressing Bla2. In addition to this work, aptamers were investigated as a potential means of future inhibitor design.Item Purification, characterization, and kinetic analysis of various metallo-β-lactamases and discovery of novel inhibitors of these enzymes.(2014-06-11) Schlesinger, Sara Rae.; Kim, Sung-Kun, 1968-; Chemistry and Biochemistry.; Baylor University. Dept. of Chemistry and Biochemistry.Pathogenic bacteria are rapidly becoming antibiotic resistant, at a rate much faster than the production and FDA approval of new antibiotics that can combat these extreme resistant infections. One way to overcome antibiotic resistance is to design inhibitors that shut down current resistance pathways in order for traditionally useful antibiotics to be reintroduced in combination with the new inhibitor to cure these types of infections. One major contributor to antibiotic resistance are enzymes known as β-lactamases, which render the current most widely prescribed class of antibiotics inactive. This work describes the purification of the enzyme Bla2, a metallo-β-lactamase which confers antibiotic resistance to Bacillus anthracis. Aspects of the enzyme’s activity and stability are investigated to find an optimal setting in which potential inhibitors can be analyzed. Three classes of inhibitors are investigated against this enzyme: compounds containing hydroxamate residues, a compound containing a zinc binding group, and a set of DNA/PNA aptamers previously developed by SELEX technology. The hydroxamate compound N-hydroxy-3-((6-(hydroxyamino)-6-oxohexyl)oxy)benzamide exhibited promising inhibitory activity against Bla2 as well as inhibition of growth of Escherichia coli cells expressing the enzyme. The compound that contains the zinc binding group, known as thiomaltol, inhibits Bla2 more strongly than when employed against other metal containing enzymes and is a reversible, slow-binding inhibitor of Bla2, which may provide a clinical advantage for this compound when co-administered with a β-lactam antibiotic. Also, DNA/PNA aptamers were examined against Bla2 and have some inhibitory activity against the enzyme as well as Bacillus subtilis cells expressing Bla2. In addition to Bla2, a truncated version of the metallo-β-lactamase NDM-1 from Klebsiella pneumoniae was purified and kinetically characterized in order to aid in future inhibitor design of this potent enzyme. In conclusion, various metallo-β-lactamases were successfully purified, characterized, and various classes of inhibitors were investigated against Bla2 which have potential as lead compounds to direct future efforts in novel antibiotic design.